Rufinamide

BreastfeedingGeriatric
  • TRADE NAMES: Banzel (Eisai); Inovelon (Eisai); Xilep
  • INDICATIONS: Epilepsy, Lennox-Gastaut syndrome
  • CLASS: Antiepileptic
  • HALF-LIFE: 6–10 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Carbamazepine, Lamotrigine, Phenobarbital, Primidone, Topiramate, Valproic Acid, Vigabatrin

PREGNANCY CATEGORY: C

Contra-indicated in patients with familial short QT syndrome.

Our database has 62 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 08/01/2022

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top